NASDAQ:IBB iShares Biotechnology ETF (IBB) Price, Holdings, & News $137.73 +1.53 (+1.12%) (As of 07/8/2024 ET) Add Compare Share Share Today's Range$136.87▼$138.0150-Day Range$126.92▼$139.9652-Week Range$111.83▼$141.16Volume1.40 million shsAverage Volume1.05 million shsMarket Capitalization$7.37 billionAssets Under Management$7.28 billionDividend Yield0.29%Net Expense Ratio0.45% Stock AnalysisStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestTrendsStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestTrends Get iShares Biotechnology ETF alerts: Email Address About iShares Biotechnology ETF (NASDAQ:IBB)iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.Read More IBB Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IBB ETF News HeadlinesJuly 3, 2024 | marketbeat.comAbbVie Stock: A Perfect Dip for Investors to Buy (IBB)ABBV stock is down over 3% to start the second half of the year; the stock may be overvalued in the short term but still offers value for long-term investorsJuly 2, 2024 | marketbeat.comBiotech Stock Breakout: IBB Eyes Resistance with Amgen and VertexThe biotechnology sector, represented by the iShares Biotechnology ETF NASDAQ: IBB, has experienced a year of consolidation. With the ETF up just 0.8%, it has underperformed the broader market, making it one of the worst-performing sectors year-to-date.July 9, 2024 | Weiss Ratings (Ad)The only way to play the AI boom?A new AI profit window is opening. But I believe if you want to take advantage of this next wave of AI … You have to do something very few people will have the courage to do.July 2, 2024 | marketbeat.comBiotech Stock Breakout: IBB Eyes Resistance with Amgen and VertexThe biotech sector (IBB) is trading just 3% away from its 52-week high and a significant resistance level, suggesting a potential breakout.July 8 at 1:22 PM | americanbankingnews.comiShares Biotechnology ETF Sees Unusually High Options Volume (NASDAQ:IBB)May 29, 2024 | investing.comTransportation Stocks Are Selling Off Without a CatalystMay 27, 2024 | investing.comSemiconductors Shine, But Outlook for Other Sectors Remains MixedMay 24, 2024 | investorplace.comWhy the Rest of 2024 Could Be Good for Investing in Biotech StocksJuly 9, 2024 | Weiss Ratings (Ad)The only way to play the AI boom?A new AI profit window is opening. But I believe if you want to take advantage of this next wave of AI … You have to do something very few people will have the courage to do.May 10, 2024 | seekingalpha.comIGV: The Software ETF Will Eventually Share In The Love We're Now Giving To SemiconductorsSee More Headlines Receive IBB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iShares Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssueriShares Fund NameiShares Biotechnology ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:IBB Inception Date2/5/2001 Fund ManagerDiane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkICE Biotechnology Index (TR) (USD) CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings221 Fund Statistics Assets Under Management$7.28 billion Average Daily Volume$1.13 million Discount/Premium-0.03% Administrator, Advisor and Custodian AdministratorJPMorgan Chase Bank, N.A. AdvisorBlackRock Fund Advisors CustodianJPMorgan Chase Bank, N.A. DistributorBlackRock Investments, LLC Transfer AgentJPMorgan Chase Bank, N.A. TrusteeN/A Lead Market MakerLatour Trading Options OptionableOptionable Options Volume3,609 Put Options1,555 Call Options2,054 Short Interest8,740,000 shs Miscellaneous Outstanding Shares53,500,000Beta0.84 Creation Unit50,000 Creation Fee$614.00 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Ad Weiss RatingsThe only way to play the AI boom?A new AI profit window is opening. But I believe if you want to take advantage of this next wave of AI … You have to do something very few people will have the courage to do.Click here to find out more before it’s too late. iShares Biotechnology ETF ExpensesTypeIBBHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.45%0.56%0.54%0.48%0.51%Other Expenses0.00%0.33%0.50%0.39%0.54%Total Expense0.45%0.70%0.70%0.60%0.71%Fee Waiver0.00%-0.45%-0.55%-0.32%-0.59%Net Expense0.45%0.61%0.60%0.54%0.59% iShares Biotechnology ETF (IBB) Holdings & ExposureTop 10 IBB HoldingsRegeneron Pharmaceuticals(NASDAQ:REGN)Holding Weight: 8.30%Vertex Pharmaceuticals(NASDAQ:VRTX)Holding Weight: 8.19%Gilead Sciences(NASDAQ:GILD)Holding Weight: 8.16%Amgen(NASDAQ:AMGN)Holding Weight: 7.99%Moderna(NASDAQ:MRNA)Holding Weight: 4.04%IQVIA(NYSE:IQV)Holding Weight: 3.73%Biogen(NASDAQ:BIIB)Holding Weight: 3.31%Alnylam Pharmaceuticals(NASDAQ:ALNY)Holding Weight: 3.20%Mettler-Toledo International(NYSE:MTD)Holding Weight: 2.87%argenx(NASDAQ:ARGX)Holding Weight: 2.23%IBB Sector ExposureIBB Industry ExposureFull Holdings Details Key ExecutivesGeorge G. C. Parker Ph.D.Independent Chairman of the Board of TrusteesMichael Arthur LathamPresident, TrusteeJack GeeChief Financial Officer, TreasurerGeoffrey D. FlynnChief Operating Officer, Executive Vice PresidentBio & Compensation - Amy SchioldagerExecutive Vice PresidentIra P. ShapiroVice President, Chief Legal OfficerMatt TuckerVice PresidentBio & Compensation - Eilleen M. ClavereSecretaryCecilia H. HerbertIndependent TrusteeCharles A. HurtyIndependent TrusteeMore ExecutivesSimilar ETFsVanEck Pharmaceutical ETFNASDAQ:PPHVanEck Biotech ETFNASDAQ:BBHInvesco S&P SmallCap Health Care ETFNASDAQ:PSCHInvesco Dorsey Wright Healthcare Momentum ETFNASDAQ:PTHProShares Ultra Nasdaq BiotechnologyNASDAQ:BIBInstitutional OwnershipAppleton Partners Inc. MABought 735 shares on 7/2/2024Ownership: 0.136%Transcend Capital Advisors LLCSold 83 shares on 7/2/2024Ownership: 0.020%Massmutual Trust Co. FSB ADVBought 1,530 shares on 7/2/2024Ownership: 0.004%Neville Rodie & Shaw Inc.Sold 261 shares on 7/1/2024Ownership: 0.087%Bank of New HampshireSold 350 shares on 7/1/2024Ownership: 0.006%View All Institutional Transactions IBB ETF - Frequently Asked Questions How have IBB shares performed this year? iShares Biotechnology ETF's stock was trading at $135.85 at the beginning of 2024. Since then, IBB shares have increased by 1.4% and is now trading at $137.73. View the best growth stocks for 2024 here. When did iShares Biotechnology ETF's stock split? iShares Biotechnology ETF shares split on Friday, December 1st 2017. The 3-1 split was announced on Tuesday, November 7th 2017. The newly issued shares were payable to shareholders after the closing bell on Thursday, November 30th 2017. An investor that had 100 shares of stock prior to the split would have 300 shares after the split. Who are iShares Biotechnology ETF's major shareholders? iShares Biotechnology ETF's top institutional shareholders include Appleton Partners Inc. MA (0.14%), Neville Rodie & Shaw Inc. (0.09%), Transcend Capital Advisors LLC (0.02%) and Bank of New Hampshire (0.01%). How do I buy shares of iShares Biotechnology ETF? Shares of IBB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of iShares Biotechnology ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that iShares Biotechnology ETF investors own include NVIDIA (NVDA), Walt Disney (DIS), Netflix (NFLX), Alibaba Group (BABA), Tesla (TSLA), Cisco Systems (CSCO) and Micron Technology (MU). This page (NASDAQ:IBB) was last updated on 7/9/2024 by MarketBeat.com Staff From Our PartnersBitcoin’s Biggest Year Yet2024 is set to be a historic year for Bitcoin. It’s all thanks to three major catalysts that I reveal in my...Paradigm Press | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredYoung billionaire opens the door for millions of AmericansYou can now profit from a catalog of 11 inventions that will likely make their way into millions of U.S. house...Porter & Company | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | SponsoredExposed: 3 CENT Crypto to Explode June 24th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredGrab Your Free Bitcoin Today!And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a v...Crypto Swap Profits | SponsoredThe asset beating inflation by 4xCentral Bank Gold Heist In Progress Central banks are buying gold at record rates... and billionaire invest...Colonial Metals | SponsoredTrump’s Gift Could Unleash $51 Billion in New WealthIn January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house...Wealthpin Pro | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IBB Stock Alerts